BSX (Boston Scientific) Growth Rank: 10 (As of Sep. 05, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSX Boston Scientific Corp BSX
77 GF Score
Price $47.80
GF Value $107.17
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Growth Rank?

Boston Scientific BSX +1.81% 77 Growth Rank is 10 as of Sep. 05, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates BSX with a GF Score™ of 77/100 and a GF Value™ of $107.17 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Boston Scientific has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Boston Scientific Growth Rank Related Terms

BSX vs EW, DXCM, GEHC: Growth Rank Comparison

For the Medical Devices subindustry, Boston Scientific's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Growth Rank distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Growth Rank falls into.


BSX
77GF Score
Boston Scientific Corp BSX
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Boston Scientific (BSX) has a Growth Rank of 10 as of Sep. 05, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Boston Scientific and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, Boston Scientific's Growth Rank has ranged from 1.00 to 10.00.
Is Boston Scientific's Growth Rank too high?
Boston Scientific's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Boston Scientific has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Growth Rank compare to EW and DXCM?
Boston Scientific's Growth Rank of 10 can be compared against companies in the Medical Devices & Instruments industry. Historically, Boston Scientific's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Boston Scientific and its competitors. Boston Scientific's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.17, compared to a current price of $47.80 — trading 55.4% below its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. Boston Scientific's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Boston Scientific (BSX), the current Growth Rank is 10 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of $47.80 is trading 55.4% below its estimated GF Value™ of $107.17. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for BSX:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: $107.17 vs. price of $47.80 (55.4% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
77GF Score

Get the complete analysis for BSX

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$47.80
Price
$107.17
GF Value